Thermo Fisher Scientific (TMO) Other Non-Current Assets (2009 - 2026)

Thermo Fisher Scientific has disclosed Other Non-Current Assets across 18 years of filings, most recently posting $6.0 billion for Q1 2026.

• Quarterly Other Non-Current Assets rose 32.26% year-over-year to $6.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 billion (up 32.26% YoY) and the FY2025 annual result came in at $5.9 billion, up 30.7% from the prior year.
• Other Non-Current Assets rose to $6.0 billion in Q1 2026, from $5.9 billion in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $6.0 billion in Q1 2026 and troughed at $4.0 billion in Q2 2023.
• A 5-year average of $4.5 billion and a median of $4.3 billion in 2022 frame the typical range for Other Non-Current Assets.
• Biggest YoY gain for Other Non-Current Assets was 79.91% in 2022; the steepest drop was 13.64% in 2022.
• Tracing TMO's Other Non-Current Assets over 5 years: stood at $4.0 billion in 2022, then decreased by 0.2% to $4.0 billion in 2023, then rose by 12.33% to $4.5 billion in 2024, then soared by 30.7% to $5.9 billion in 2025, then advanced by 1.74% to $6.0 billion in 2026.
• Business Quant data shows TMO's Other Non-Current Assets at $6.0 billion in Q1 2026, $5.9 billion in Q4 2025, and $5.0 billion in Q3 2025.